Author

Tara L. Hogenson

Mayo ClinicORCID 0000-0002-6246-6987Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Ahmed M. ElhossinyiD· 1 shared Allison R. SchulmaniD· 1 shared Arvind U.K. RaoiD· 1 shared Aylin Z. HenstridgeiD· 1 shared Costas Andreas LyssiotisiD· 1 shared Eileen S. CarpenteriD· 1 shared Erik‐Jan WamstekeriD· 1 shared Filip BednariD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmed M. ElhossinyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer

Aylin Z. Henstridge, Peter A. Azorsa, Nandini Arya, Ahmed M. Elhossiny, Padma Kadiyala, Molly Goldwasser, Georgina Branch, Vaibhav Sahai, Nicole Peterson, Jorge D. Machicado, Richard S. Kwon, Allison R. Schulman, Erik‐Jan Wamsteker, George Philips, Stacy B. Menees, , Eileen S. Carpenter

The paper analyzes matched pre- and post-chemotherapy biospecimens in pancreatic cancer, revealing that cancer-associated fibroblasts undergo neural reprogramming, characterized by axonal guidance gene enrichment, which may contribute to chemoresistance and tumor progression.

Cancer Research · Sep 21, 2026Peer-reviewedCancer Biology